Insulin-like Growth Factor I Receptor Antagonism Augments Response to Chemoradiation Therapy in Colon Cancer Cells
- 30 November 2000
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 94 (1) , 1-5
- https://doi.org/10.1006/jsre.2000.5923
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Expression of insulin-like growth factor-1 receptor in human colorectal cancerHuman Pathology, 1999
- Dysregulation of the Type 1 IGF receptor as a paradigm in tumor progressionMolecular and Cellular Endocrinology, 1998
- Insulin-like growth factor-I promotes multidrug resistance in MCLM colon cancer cellsJournal of Cellular Physiology, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Proliferation of human colon cancer cells: Role of epidermal growth factor and transforming growth factorαInternational Journal of Cancer, 1992
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trialBritish Journal of Surgery, 1989
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Adjuvant Chemotherapy in Cancer of the Colon and Rectum: Demonstration of Effectiveness of Prolonged 5-FU Chemotherapy in a Prospectively Controlled, Randomized TrialSurgical Clinics of North America, 1981